Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on OYE1 Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113444702B reveals high-efficiency OYE1 mutant for Brivaracetam intermediate production, offering superior conversion and ee values for scalable API manufacturing.